Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Imagineering Finishing to be featured on 21st Century Business Television March 3, 2012

(EMAILWIRE.COM, March 01, 2012 ) Boca Raton, FL --- Metals are an essential component in the function of today’s society. Metals constitute important parts of cars, bikes, planes, surgical tools, computers, and can even be part of your medically repaired body in the form of a knee or hip. Imagineering Finishing Technologies is a provider of metallurgical consulting and process applications in a wide range of markets where high precision and critical tolerances must be met.

Through their dedication to the values of Total Quality Management, Imagineering is a customer centric organization that strives to develop an intimate relationship with each and every one of their customers and employees. This exceptional dynamic ensures their customers receive the best metal finishing solutions possible while ensuring smooth supply chain management
Globally acknowledged as the KnowledgeSource ™ for Metal Finishing, Imagineering provides world class quality and environmental standards. Electroless nickel plating, phosphate and chromate conversion coatings, dry-film lubricants, specialty paints and testing – Imagineering provides metal finishing solutions beyond the surface.

President and CEO F. James Hammer stated, “It is not as important of what we think of ourselves – it’s what the customer experiences that matters the most”

JL Haber, Vice President of Programming at Multi Media Productions, added, “Imagineering Finishing is an innovator and a leader in its industry, which makes the company a natural fit for our show. We are excited to have them on the program.”

About Imagineering Enterprises
Imagineering Enterprises was founded in 1959 by David E. Huber, a Notre Dame School of Metallurgical Science graduate. While working at a National Space science lab, he formed the notion of a company to have as its business mission to innovate to decipher everyday engineering problems related to wear and corrosion of metallic substrates. He developed boutique coatings for aerospace and automotive application during his career and consulted many of the Fortune 1000 industrial firms. He sold his business to the current President/CEO, Jim Hammer, in 1996. Mr. Hammer has used his experience and business education to develop Imagineering into one of the leading applied metal finishing and consulting firms in the world.

To learn more about Imagineering Enterprises, please visit http://www.iftworldwide.com.

About 21st Century Business
21st Century Business is an award winning television series produced by Multi-Media Productions. The show features companies providing business viewers an in depth opportunity to find solutions within many industries globally.

21st Century Business airs on CNBC and the Fox Business Network to over 100 million viewers nationwide as well as internationally via DirecTV and Dish Network. The show can also be viewed through video on demand via http://www.21cbtv.com. The series is also available at more than 27 prestigious college universities, including Carnegie Mellon University, Howard University, Dartmouth College and Georgetown University.

For specific market-by-market air dates and times, please e-mail Moniqueh@mmpusa.com. For more information, please visit http://www.21cbtv.com.



Multi-Media Productions USA
Susan Waters
919 732 3070
swaters@mmpusa.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


$1,000 Sovaldi now hepatitis treatment of choice
29 Jul 2014 at 3:47pm

WASHINGTON (AP) ? The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million.



5 food writers subpoenaed in 'pink slime' lawsuit
29 Jul 2014 at 5:54pm

Several food writers, including a New York Times reporter, have been subpoenaed by a meat producer as part of its $1.2 billion defamation lawsuit against ABC in regards to the network's coverage of a beef product dubbed "pink slime" by critics.



Generation of tanners see spike in deadly melanoma
29 Jul 2014 at 6:30pm

WASHINGTON (AP) ? Stop sunbathing and using indoor tanning beds, the acting U.S. surgeon general warned in a report released Tuesday that cites an alarming 200 percent jump in deadly melanoma cases since 1973.



Pfizer to buy Baxter's vaccines unit for $635 million
30 Jul 2014 at 6:39am

(Reuters) - Pfizer Inc agreed on Wednesday to buy Baxter International Inc's vaccines unit and a part of a production facility for $635 million. The deal will give Pfizer access to Baxter's meningitis vaccine, NeisVac-C, and its encephalitis vaccine, FSME-IMMUN. Pfizer will also get access to a portion of Baxter's facility in Austria where the vaccines are made. Both vaccines are currently available outside the United States, primarily in a number of European markets.



Kids are accepting healthier school lunches: survey
30 Jul 2014 at 6:30am

By Shereen Lehman NEW YORK (Reuters Health) - A recent study suggests that most elementary age students are okay with eating the healthier school lunches required by the USDA. Despite early complaints from kids when the new menus were introduced in the fall of 2012, researchers found that by the second half of the school year, sales of school meals were up among disadvantaged kids, an important target audience for the healthier fare. ?At 70 percent of elementary schools across the country, school leaders perceived that students liked the new lunches,? Lindsey Turner, coauthor of the study, told Reuters Health. ?This is great news, as it suggests that students generally have been quite accepting of the standards, which have substantially improved the nutritional quality of school meals,? said Turner, a researcher at Boise State University in Idaho.



Ireland has too much to lose to deter U.S. companies re-homing
30 Jul 2014 at 6:13am

By Padraic Halpin DUBLIN (Reuters) - Ireland is in the firing line from Washington again for luring U.S. companies to its shores for tax benefits, but despite contrite noises coming from Dublin, it has too much to lose to discourage U.S. firms bent on shifting their tax domiciles. Ireland's low corporate tax rate of 12.5 percent is a natural lure for U.S. companies looking to set up an overseas hub, and for Dublin the pay-off is new jobs, but in so-called inversion deals the company then switches its overall tax domicile from the United States, where the rate is 35 percent, to its new home. The surge in such deals, which are typically effected by purchasing an overseas company - which does not then necessarily create any new jobs - drew the ire of President Barack Obama last week, who singled out Ireland for criticism. Ireland's government has responded by saying it is looking at ways of stopping the transactions, but lawyers and tax advisors who work for multinationals such as Intel , Pfizer and Google say little can be done without putting at risk a model specifically designed to lure foreign companies.


WellPoint medical cost ratio drives second-quarter profit beat
30 Jul 2014 at 5:18am
(Reuters) - U.S. health insurer WellPoint Inc on Wednesday reported a decline in second-quarter profit, but its closely watched medical costs as a percentage of premiums ratio improved and it beat Wall Street estimates. WellPoint, which runs Anthem and Empire Blue Cross Blue Shield Plans, is the third large health insurer to beat analysts' earnings estimates for the quarter but shares have sold off as investors worried that a run in low medical costs might be ending. WellPoint beat Wall Street expectations because this ratio was less than foreseen, Leerink Partners analyst Ana Gupte said in a research note. WellPoint said it spent 82.7 percent of the premiums that it brought in on medical claims in what is known as the medical benefit expense ratio.

At least 34 killed in stampede at Guinea beach concert
30 Jul 2014 at 5:18am
By Saliou Samb CONAKRY (Reuters) - At least 34 people, including several children, were killed in a stampede at a beachside rap concert celebrating the end of Ramadan in Guinea's capital Conakry, medical sources said on Wednesday. The stampede, which occurred during celebrations to mark the end of the holy fasting month of Ramadan in mainly Muslim Guinea, comes at a time when health workers are stretched by an outbreak of Ebola.


Sanofi, Regeneron drug cuts cholesterol in nine late-stage trials
30 Jul 2014 at 5:06am

By Natalie Huet PARIS (Reuters) - A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday. The injectable drug, called alirocumab, is from a promising new class of medicines, called PCSK9 inhibitors, also being developed by Amgen Inc and other drugmakers. The Phase III ODYSSEY trials showed that after 24 weeks, the mean percentage reduction in LDL cholesterol with alirocumab was consistent with results seen in previous trials, the companies said in a statement. The trials involved patients whose high LDL cholesterol levels are not sufficiently controlled by existing treatments such as statins, who cannot tolerate these or who present a high or very high cardiovascular risk.



AstraZeneca buys Almirall lung drugs for up to $2.1 billion
30 Jul 2014 at 4:51am

By Ben Hirschler LONDON (Reuters) - AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion for the rights to Spanish group Almirall's lung drugs. The British drugmaker, which resisted a $118 billion takeover attempt by Pfizer in May, said it would pay an initial $875 million and up to $1.22 billion more if the drugs meet development and sales targets. The tie-up boosts a key therapeutic area for AstraZeneca, whose Chief Executive Pascal Soriot is determined to show his company has a strong independent future. Soriot also struck a clinical trial collaboration with Japan's Kyowa Hakko Kirin for a study that will evaluate a combination of the two companies' drugs in cancer - another important field for AstraZeneca.


Humana says profit fell on health reform, drug costs
30 Jul 2014 at 3:55am
(Reuters) - U.S. health insurer Humana Inc said on Wednesday that second-quarter profit fell due to investments in the exchanges created under President Barack Obama's healthcare reform law as well as costly new hepatitis C drug treatments. Humana said membership growth and a lower share count due to stock buybacks had helped offset some of the new costs. Most of Humana's revenue is from Medicare Advantage and Medicare Part D, the privately run medical and drug plans under the government health program for older people and the disabled. Humana said revenue rose 18 percent to $12.2 billion.

Koch-backed seniors group low-balling election spending?
30 Jul 2014 at 2:00am
The 60 Plus Association tells the IRS it barely spends money on politics ? despite funding millions in candidate attack ads.


UK Foreign Secretary says Ebola outbreak "a threat" to Britain
30 Jul 2014 at 1:42am

LONDON (Reuters) - British Foreign Secretary Philip Hammond said he would hold a top-level government meeting to discuss the outbreak of the highly-infectious Ebola virus across West Africa which he warned posed a threat to Britain. "It is a threat. It is something we need to respond to," Hammond told BBC TV. Ebola is believed to have killed 672 people in Guinea, Liberia and Sierra Leone since the outbreak began in February, according to the World Health Organisation. ...



Sierra Leone's top Ebola doctor dies from virus
30 Jul 2014 at 1:39am

By Umaru Fofana and Adam Bailes FREETOWN (Reuters) - The doctor leading Sierra Leone's fight against the worst Ebola outbreak on record died from the virus on Tuesday, the country's chief medical officer said. The death of Sheik Umar Khan, who was credited with treating more than 100 patients, follows those of dozens of local health workers and the infection of two American medics in neighbouring Liberia, highlighting the dangers faced by staff trying to halt the disease's spread across West Africa. Ebola is believed to have killed 672 people in Guinea, Liberia and Sierra Leone since the outbreak began in February, according to the World Health Organisation. The contagious disease, which has no known cure, has symptoms that include vomiting, diarrhoea and internal and external bleeding.



Hammond says Ebola outbreak 'a threat' to Britain
30 Jul 2014 at 12:33am

Foreign Secretary Philip Hammond said he would hold a top-level government meeting to discuss the outbreak of the highly-infectious Ebola virus across West Africa which he warned posed a threat to Britain. Ebola is believed to have killed 672 people in Guinea, Liberia and Sierra Leone since the outbreak began in February, according to the World Health Organisation. Hammond said no British citizens were believed to be affected and no cases had been reported in Britain, but said he would chair an emergency meeting of officials on Wednesday to look at what precautions were needed.


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC